APOE and Congenital factor II deficiency: Therefore, we employed uniformly viable FII heterozygous ApoE−/− mice (characterized by hypoprothrombinemia and diminished FVII and thrombin generation but no spontaneous bleeding risk; Table S1A) in comparative studies with control, prothrombin-sufficient ApoE−/− mice.